AAAAAA
Results: 1-25/37
Authors:
Stingl, G
Maurer, D
Citation: G. Stingl et D. Maurer, Langerhans cell migration, CELL ADHES, 8, 2001, pp. 241-249
Authors:
Strohal, R
Mosser, R
Kittler, H
Wolff, K
Jansen, B
Brna, C
Stingl, G
Pehamberger, H
Citation: R. Strohal et al., MART-1/Melan-A and tyrosinase transcripts in peripheral blood of melanoma patients: PCR analyses and follow-up testing in relation to clinical stage and disease progression, MELANOMA RE, 11(5), 2001, pp. 543-548
Authors:
Cooper, KD
Christophers, E
Saurat, JH
Stingl, G
Citation: Kd. Cooper et al., Understanding atopic dermatitis: Pathophysiology and etiology - Introduction - Discussion, J AM ACAD D, 45(1), 2001, pp. S3-S3
Authors:
Saurat, JH
Leung, DYM
Stingl, G
Citation: Jh. Saurat et al., Atopic dermatitis and the immune system: The role of superantigens and bacteria - Discussion, J AM ACAD D, 45(1), 2001, pp. S16-S16
Authors:
Stingl, G
Citation: G. Stingl, IgE-mediated, Fc epsilon RI-dependent allergen presentation: A pathogenetic factor in atopic dermatitis?, J AM ACAD D, 45(1), 2001, pp. S17-S20
Authors:
Leung, DYM
Stingl, G",DeVries
Citation: Dym. Leung et Stingl, G",devries, IgE-mediated, Fc epsilon RI-dependent allergen presentation: A pathogenetic factor in atopic dermatitis? Discussion, J AM ACAD D, 45(1), 2001, pp. S20-S20
Authors:
Geusau, A
Abraham, K
Geissler, K
Sator, MO
Stingl, G
Tschachler, E
Citation: A. Geusau et al., Severe 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) intoxication: Clinical and laboratory effects, ENVIR H PER, 109(8), 2001, pp. 865-869
Authors:
Kopp, T
Kieffer, JD
Rot, A
Strommer, S
Stingl, G
Kupper, TS
Citation: T. Kopp et al., Inflammatory skin disease in K14/p40 transgenic mice: Evidence for interleukin-12-like activities of p40, J INVES DER, 117(3), 2001, pp. 618-626
Authors:
Kriehuber, E
Breiteneder-Geleff, S
Groeger, M
Soleiman, A
Schoppmann, SF
Stingl, G
Kerjaschki, D
Maurer, D
Citation: E. Kriehuber et al., Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages, J EXP MED, 194(6), 2001, pp. 797-808
Authors:
Fiebiger, E
Meraner, P
Weber, E
Fang, IF
Stingl, G
Ploegh, H
Maurer, D
Citation: E. Fiebiger et al., Cytokines regulate proteolysis in major histocompatibility complex class II-dependent antigen presentation by dendritic cells, J EXP MED, 193(8), 2001, pp. 881-892
Authors:
Schneeberger, A
Goos, M
Stingl, G
Wagner, SN
Citation: A. Schneeberger et al., Molecular strategies interfering with tumor progression of melanoma and improving anti-tumor immunity, SKIN AND GENE THERAPY, 2001, pp. 245-273
Authors:
Gottfried, I
Seeber, A
Anegg, B
Rieger, A
Stingl, G
Volc-Platzer, B
Citation: I. Gottfried et al., High dose intravenous immunoglobulin (IVIG) in dermatomyositis: clinical responses and effect on sIL-2R levels, EUR J DERM, 10(1), 2000, pp. 29-35
Authors:
Cascinelli, N
Heerlyn, M
Schneeberger, A
Kuwert, C
Slominski, A
Armstrong, C
Belli, F
Lukiewcz, S
Maurer, D
Ansel, J
Stingl, G
Saida, T
Citation: N. Cascinelli et al., What is the most promising strategy for the treatment of metastasizing melanoma?, EXP DERMATO, 9(6), 2000, pp. 439-451
Authors:
Schneeberger, A
Goos, M
Stingl, G
Wagner, SN
Citation: A. Schneeberger et al., Management of malignant melanoma: new developments in immune and gene therapy, CLIN EXP D, 25(6), 2000, pp. 509-519
Authors:
Zuberbier, T
Henz, BM
Fiebiger, E
Maurer, D
Stingl, G
Citation: T. Zuberbier et al., Anti-Fc(epsilon)RI alpha serum autoantibodies in different subtypes of urticaria, ALLERGY, 55(10), 2000, pp. 951-954
Authors:
Valenta, R
Seiberler, S
Natter, S
Mahler, V
Mossabeb, R
Ring, J
Stingl, G
Citation: R. Valenta et al., Autoallergy: A pathogenetic factor in atopic dermatitis?, J ALLERG CL, 105(3), 2000, pp. 432-437
Authors:
Wagner, SN
Wagner, C
Luhrs, P
Weimann, TK
Kutil, R
Goos, M
Stingl, G
Schneeberger, A
Citation: Sn. Wagner et al., Intracutaneous genetic immunization with autologous melanoma-associated antigen Pmel17/gp100 induces T cell-mediated tumor protection in vivo, J INVES DER, 115(6), 2000, pp. 1082-1087
Authors:
Elbe-Burger, A
Mommaas, AM
Prieschl, EE
Fiebiger, E
Baumruker, T
Stingl, G
Citation: A. Elbe-burger et al., Major histocompatibility complex class II- fetal skin dendritic cells are potent accessory cells of polyclonal T-cell responses, IMMUNOLOGY, 101(2), 2000, pp. 242-253
Authors:
Geusau, A
Jurecka, W
Nahavandi, H
Schmidt, JB
Stingl, G
Tschachler, E
Citation: A. Geusau et al., Punctate keratoderma-like lesions on the palms and soles in a patient withchloracne: a new clinical manifestation of dioxin intoxication?, BR J DERM, 143(5), 2000, pp. 1067-1071
Authors:
Silberer, M
Koszik, F
Stingl, G
Aberer, E
Citation: M. Silberer et al., Downregulation of class II molecules on epidermal Langerhans cells in Lymeborreliosis, BR J DERM, 143(4), 2000, pp. 786-794
Authors:
Geusau, A
Heinz-Peer, G
Volc-Platzer, B
Stingl, G
Kirnbauer, R
Citation: A. Geusau et al., Regression of deeply infiltrating giant condyloma (Buschke-Lowenstein tumor) following long-term intralesional interferon alfa therapy, ARCH DERMAT, 136(6), 2000, pp. 707-710
Authors:
Schreiber, S
Kampgen, E
Wagner, E
Pirkhammer, D
Trcka, J
Korschan, H
Lindemann, A
Dorffner, R
Kittler, H
Kasteliz, F
Kupcu, Z
Sinski, A
Zatloukal, K
Buschle, M
Schmidt, W
Birnstiel, M
Kempe, RE
Voigt, T
Weber, HA
Pehamberger, H
Mertelsmann, R
Brocker, EB
Wolff, K
Stingl, G
Citation: S. Schreiber et al., Immunotherapy of metastatic malignant melanoma by a vaccine consisting of autologous interleukin 2 transfected cancer cells: Outcome of a phase I study, HUM GENE TH, 10(6), 1999, pp. 983-993
Authors:
Knapp, S
Turnherr, M
Dekan, G
Willinger, B
Stingl, G
Rieger, A
Citation: S. Knapp et al., A case of HIV-associated cerebral histoplasmosis successfully treated withfluconazole, EUR J CL M, 18(9), 1999, pp. 658-661
Authors:
Geusau, A
Tschachler, E
Meixner, M
Sandermann, S
Papke, O
Wolf, C
Valic, E
Stingl, G
McLachlan, M
Citation: A. Geusau et al., Olestra increases faecal excretion of 2,3,7,8-tetrachlorodibenzo-p-dioxin, LANCET, 354(9186), 1999, pp. 1266-1267
Authors:
Abrams, D
Allan, D
Antunes, F
Breckenridge, A
Bruun, J
Cameron, W
Carbon, C
Chalmers, I
Chang, H
Chodakewitz, J
Clendenin, N
Clumeck, N
Collier, A
Collins, G
Cooper, E
Cooper, D
Danner, S
D'Aquila, R
DeGruttola, V
DeMasi, R
Dee, L
Deyton, L
Dixon, D
Farthing, C
Feinberg, J
Fischl, M
Flepp, M
Gartland, M
Gatell, J
Gazzard, B
Goebel, F
Gotzsche, P
Gringeri, A
Hall, D
Hamilton, J
Hammer, S
Hartigan, P
Heath-Chiozzi, M
Henry, K
Hill, A
Hirschel, B
Ioannidis, J
Kahn, J
Katlama, C
Katzenstein, D
Killen, J
King, E
de Loes, SK
Kravcik, S
Lange, J
Leavitt, R
Leonard, J
Maeland, A
Mannucci, P
Mathiesen, L
McDade, H
Meibohn, A
Melander, H
Merigan, T
Mulder, J
Myers, M
Neaton, J
Nessling, M
Perrin, L
Pettinelli, C
Phair, J
Phillips, A
Pinching, A
Poppa, A
Power, L
Reiss, P
Richman, D
Rooney, J
Rousseau, F
Rutherford, G
Salgo, M
Sandstrom, E
Saravolatz, L
Savidge, G
Schnittman, S
Schooley, R
Seligmann, M
Simberkoff, M
Skowron, G
Slade, P
Smith, D
Smith, RP
Soriano, V
Stanley, K
Stingl, G
Stoffels, P
Struthers, L
Tierney, C
Thompson, M
Van der Broeck, R
Van Leeuven, R
Van Weverling, G
Veenstra, J
Vella, S
Volberding, P
Weber, J
Winslow, D
Yeni, P
Yeo, J
Dormont, J
Sande, M
Weller, I
Babiker, A
Collins, R
Darbyshire, J
Duncan, W
Foulkes, M
Hughes, M
Peto, R
Peto, T
Walker, S
Citation: D. Abrams et al., Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection:meta-analyses of the randomised evidence, LANCET, 353(9169), 1999, pp. 2014-2025